MPs criticize slow rollout plan for fat jabs, citing limited early access

A select committee has expressed dissatisfaction with the slow rollout plan for fat jabs, specifically the drug Mounjaro, noting that only 6% of eligible patients are expected to receive it within the first three years. This criticism highlights concerns about access and distribution speed for the treatment.

Originally published by gnews